Gynecomastia Procedures Market Revenue Growth and Industry Development Forecast 2034
Gynecomastia Procedures Market Revenue Growth and Industry Development Forecast 2034
The Gynecomastia procedures market trends in 2026 are treatments used to reduce enlarged male breast tissue and create a flatter chest shape. The market primarily includes surgical correction of excess chest fat, gland tissue, or both. Market growth is supported by increasing numbers of men seeking treatment for body confidence, comfort, and mental well-being. Rising awareness of male aesthetic procedures is also contributing to demand.
More men seek treatments for enlarged breast tissue and improved chest contour. According to Fortune Business Insights, the global market size was valued at USD 481.8 million in 2025. The market is projected to grow from USD 507.8 million in 2026 to USD 812.3 million by 2034, exhibiting a CAGR of 6.0% during the forecast period. North America dominated the market with a share of 35.82% in 2025.
The rising prevalence of obesity and lifestyle-related hormonal imbalance is a major factor supporting market growth. Increased body fat can contribute to higher estrogen activity in men, which may lead to enlarged breast tissue. Lifestyle factors such as poor diet, lack of physical activity, alcohol consumption, and certain medications can also contribute to the condition.
Improving awareness is encouraging more men to recognize gynecomastia as a treatable issue. This can increase consultation rates and support procedure demand, particularly in urban populations where lifestyle-related health concerns are more common.
A notable market trend is the increasing adoption of liposuction-led treatment approaches. Liposuction is particularly relevant when chest enlargement includes a significant fatty component. Clinics increasingly use liposuction as a starting approach because it can support chest contouring through smaller entry points and may be combined with gland excision when required.
The expansion of minimally invasive body-contouring services represents an important opportunity for the market. Providers are promoting shorter downtime, awake procedures, and faster recovery, which can make treatment more acceptable to working-age patients.
High out-of-pocket treatment costs can limit market growth because gynecomastia procedures are often considered elective or cosmetic. Patients may need to cover surgeon fees, anesthesia, facility expenses, recovery requirements, and time away from work. Limited insurance support and the presence of premium body-contouring clinics can further increase the financial barrier.
Stigma and delayed decision-making also remain important challenges. Some men may postpone treatment because of embarrassment, social stigma, or the belief that the condition will resolve on its own. Gynecomastia treatment can involve a long decision cycle, with some men delaying consultation for years. Proper diagnosis and realistic counseling are also important because the condition is not always caused by fat alone.
The competitive landscape includes major providers such as The Plastic Surgery Clinic, Transform Hospital Group, Spire Healthcare Group plc, Nuffield Health, Apollo Cosmetic Clinics, Fortis Healthcare, VLCC Health Care Ltd., Kaya Limited, Bangkok Hospital Group, and Bumrungrad International Hospital.
The Plastic Surgery Clinic (Canada)
Transform Hospital Group (U.K.)
Spire Healthcare Group plc (U.K.)
Nuffield Health (U.K.)
Apollo Cosmetic Clinics (India)
Fortis Healthcare (India)
VLCC Health Care Ltd. (UAE)
Kaya Limited (India)
Bangkok Hospital Group (Thailand)
Bumrungrad International Hospital (Thailand)
By Procedure Type (Liposuction Procedures, Excision Procedures, and Others)
By Age Group (18-40 Years and Above 40 Years)
By Indication (Physiological Gynecomastia, Drug-Induced Gynecomastia, and Others)
By Service Provider (Hospitals & ASCs, Specialty Cosmetic Surgery Clinics, and Others)
Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/gynecomastia-procedures-market-115934
North America held the dominant market share in 2025 at 35.82%. The regional market reached USD 172.6 million in 2025 and is expected to benefit from greater emphasis on male aesthetics, rising obesity prevalence, and product launches.
Europe is projected to reach USD 154.2 million in 2026 and record a growth rate of 5.5%. Growth is supported by developments in minimally invasive surgical procedures and increasing disposable incomes. Germany is projected to reach approximately USD 35.6 million in 2026, while the U.K. market is estimated at around USD 25.9 million.
Asia Pacific is estimated to reach USD 135.8 million in 2026 and become the third-largest region. Japan is estimated at USD 23.9 million, China at USD 45.5 million, and India at USD 30.5 million in 2026. Latin America is expected to reach USD 22.1 million in 2026, while the GCC market is set to reach USD 5.4 million.
The global gynecomastia procedures market is projected to reach USD 812.3 million by 2034, supported by rising demand for male aesthetic procedures, increasing awareness, minimally invasive treatment approaches, and developments in body-contouring services.
What Everyone Should Know About Japan’s Market -Gynecomastia Procedures Market- Insights